Latest Urinary Tract Infections (UTI) News
Vabomere, which combines meropenem and vaborbactam, demonstrated superior efficacy to piperacillin/tazobactam.
In a study of renal transplant patients who received ureteral stents, ciprofloxacin did not lower the incidence of UTI compared with SMX-TMP.
The researchers reaffirmed the 2011 UTI clinical practice guideline on infants and young children and reiterated the seven key action statements.
Meropenem-vaborbactam has the potential to be an important new drug in the treatment of patients with serious infections due to resistant organisms.
The researchers found no significant difference in the percent of women who had bacteriuria plus pyuria among those taking cranberry capsules or placebo.
The prevalence of UTI was 7.8% in infants tested for automated microscopic urinalysis.
In a study of 189 adult UTI patients who underwent CT scans, investigators identified bacteremia in 40.2%.
Consistent mean reductions in urinary incontinence; durable improvements in quality of life.
Fluoroquinolones such as Cipro, Levaquin should be reserved for life-threatening infections.
Researchers find new training method led to fewer urinary tract infections.
Agency is recommending that health care providers not prescribe them for certain patients.
In a study, use of the medication was associated with a significant 61% decreased risk.
Could lead to greater reliance on much more costly intravenous medications.
Case presented of patient with extended-spectrum beta-lactamase E. coli infection.
Older age and a second episode of urinary tract infection identified as risk factors.
Renal and Urology News Articles
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)